Latest immunotherapy news
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine
posted July 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma
posted July 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS
posted July 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer
posted June 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Early Survivorship Care Linked to Improved Outcomes in Head, Neck Cancer 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 Related Articles
Blinatumomab Improves Event-Free Survival in Children With High-Risk B-Cell ALL 
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported 
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors Monthly Specialist Briefings
Stay Connected
